Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …
Insys Therapeutics Inc. founder John Kapoor was convicted of a racketeering conspiracy that drove sales of a highly addictive opioid while contributing to a nationwide epidemic. Federal jurors in Boston found that Kapoor conspired with four other executives to bribe …
Federal prosecutors unveiled the first criminal charges against pharmaceutical executives for illegally diverting opioids, accusing the former chief executive officer and the head of compliance at a major U.S. drug distributor with a narcotics conspiracy. Laurence F. Doud III, who …
A U.S. prosecutor portrayed Insys Therapeutics Inc. founder John Kapoor and other former executives as greedy and heartless during closing arguments in their racketeering trial over the promotion of the opioid painkiller Subsys. Kapoor and four other ex-Insys managers “exploited” …
Insys Therapeutics Inc. founder John Kapoor didn’t cut corners when it came to collecting intelligence on opioid sales, using the data to beat down his employees and to spur doctors to prescribe more of his highly addictive painkiller, a Boston …
The goal for Insys Therapeutics Inc.’s call center in Phoenix was simple: persuade insurers to authorize at least 70 prescriptions a week of its expensive opioid spray. Workers would get bonuses for surpassing the goals, a former call center manager …
